United States $35+ Billion In Vitro Diagnostics (IVD) Market to 2024: Forecast by IVD Segment, Product and Company - ResearchAndMarkets.com

The "United
States In Vitro Diagnostics Market, Forecast by IVD Segments, Products,
Companies" report has been added to ResearchAndMarkets.com's
offering.

United States In Vitro Diagnostics (IVD) market is expected to be more
than US$ 35 Billion by the end of the year 2024.

In the United States, some of the common diagnostic tests conducted
include cholesterol level tests, blood sugar tests, HIV tests, pap
tests, tests for infectious diseases, hCG (pregnancy) tests and
substance abuse tests.

Some of the major factors stimulating the growth of the United States
IVD market include a high incidence of chronic diseases, increasing
preference for Point of Care (POC) diagnostics, technological
advancements in the field of diagnostics and increasing awareness and
acceptance regarding personalized medicine.

In addition; government favorable healthcare policy, better healthcare
infrastructure and increasing consumer's healthcare expenditure for
seeking quality healthcare further help United States IVD Market to grow
effortlessly over the forecast period.

Key Highlights

• Point of Care Testing market dominates United States In-Vitro
  Diagnostics (IVD) Market
• Instruments and Reagents are leading Products in the United States
  In-Vitro Diagnostics (IVD) Market
• South Region holds an impressive share in the United States In-Vitro
  Diagnostics (IVD) Market
  

Company Analysis

Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher
Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of
the top companies operating in the In-Vitro Diagnostics segment
globally. All the companies have been studied from three points:

• Overview
• Initiatives & Recent Developments
• Sales

Key Topics Covered

1. Introduction

2. Research & Methodology

3. United States In-Vitro Diagnostics (IVD) Market

4. Market Share - United States In-Vitro Diagnostics (IVD)
Analysis

4.1 By Segments

4.2 By Products

4.3 By Regions

5. Segments - United States In-Vitro Diagnostics (IVD) Market

5.1 Clinical Chemistry

5.2 Microbiology -ID/AST

5.3 Microbiology - Molecular

5.4 POC - Professional

5.5 POC - OTC Diabetes

5.6 POC - Others

5.7 Immunoassay - Infectious

5.8 Immunoassay - Others

5.9 Urinalysis

5.10 Molecular - Non-Infectious

5.11 Coagulation

5.12 Histology

5.13 Hematology

5.14 Blood Testing and Typing

5.15 Flow Cytometry

6. Products - United States In-Vitro Diagnostics (IVD) Market

6.1 Services

6.2 Software

6.3 Reagents

6.4 Instruments

7. Regions - United States In-Vitro Diagnostics (IVD) Market

7.1 South

7.2 West

7.3 Midwest

7.4 North East

8. Market Dynamics

8.1 Growth Drivers

8.1.1 Growth in Chronic & Infectious Disease

8.1.2 Technological Advances

8.1.3 Aging Population

8.2 Challenges

8.2.1 Cumbersome Reimbursement Procedure

8.2.2 Shortage of Lab Technicians

9. Company Analysis

9.1 Roche Diagnostics

9.1.1 Overview

9.1.2 Initiatives & Recent Developments

9.1.3 Sales

9.2 Abbott Diagnostics

9.3 Siemens Healthineers

9.4 Danaher Corporation

9.5 Thermo Fisher Scientific

9.6 Sysmex Corporation

For more information about this report visit https://www.researchandmarkets.com/r/ldvk5n

View source version on businesswire.com: https://www.businesswire.com/news/home/20190426005374/en/